News & Updates

Type 2 diabetes (T2D) patients on sodium-glucose cotransporter 2 (SGLT2) inhibitors appear to be at lower risk of dry eye disease (DED) compared with their counterparts who are receiving glucagonlike peptide-1 receptor agonists (GLP-1 RAs), as shown in a study.

Apixaban is not inferior to enoxaparin for extended-duration venous thromboembolic event (VTE) prophylaxis (EP) following urologic oncology surgery, reveals a study. In addition, apixaban is associated with fewer major complications and compliance-related adverse events.

Following negative primary results, the final follow-up of the SYMPLICITY HTN-3 trial takes a turn for the better, demonstrating significant blood pressure (BP) reductions with renal denervation (RDN) in patients with uncontrolled hypertension (HTN).

Poverty status appears to be a prominent predictor of obesity risk in children, according to a recent study.

Patients with Alzheimer’s disease (AD) show slightly dysregulated levels of plasma microRNAs (miRNA), including miRNA-92a-3p and miRNA-29a-3p, a recent study has found.

Assessments of depressive, anxiety and psychotic symptoms and suicidal risk by telepsychiatry have good reliability in general when compared with face-to-face interviews, according to researchers from the Queen Mary Hospital (QMH).